We are live on ! Find out more
TSVT icon

2seventy bio

Delisted

TSVT was delisted on the 13th of May, 2025.

116 hedge funds and large institutions have $183M invested in 2seventy bio in 2024 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 37 increasing their positions, 30 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,436% more call options, than puts

Call options by funds: $1.06M | Put options by funds: $42K

23% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 30

1.44% more ownership

Funds ownership: 91.18% → 92.62% (+1.4%)

6% more capital inflows, than outflows

Capital inflows: $27.1M | Capital outflows: $25.6M

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 19

1% less funds holding

Funds holding: 117 → 116 (-1)

Holders
116
Holders Change
-1
Holders Change %
-0.85%
% of All Funds
1.67%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
19
Increased
37
Reduced
30
Closed
19
Calls
$1.06M
Puts
$42K
Net Calls
+$1.02M
Net Calls Change
+$1.57M

TSVT Hedge Fund Activity: Q2 2024 in Review

116 of the 6,946 institutional investors tracked by Wall St. Rank reported a position in 2seventy bio (TSVT) for Q2 2024, worth a combined $183M — down 27% from $251M a quarter earlier.

Fund positioning in TSVT was balanced in Q2 2024: 19 funds opened new positions, 19 closed out, 37 added to existing stakes and 30 trimmed.

The largest buyer was Newtyn Management, opening a new position worth an estimated $11.2M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $8.63M sold.

  • 116 institutional investors held 2seventy bio (TSVT) as of Q2 2024, down from 117 in Q1 2024.
  • Funds reported $183M of 2seventy bio stock for Q2 2024, down 27% quarter-over-quarter.
  • 19 funds opened new 2seventy bio positions in Q2 2024 and 19 closed out, a net change of 0 holders.
  • The largest 2seventy bio buyer in Q2 2024 was Newtyn Management, an estimated $11.2M added.
  • The largest 2seventy bio seller in Q2 2024 was Point72 Asset Management, an estimated $8.63M sold.

Based on aggregated 13F filings for Q2 2024.